In addition to being recognised as a leading clinician in the management of hepatitis B, Ben serves on a range of national and international committees relating to viral hepatitis clinical management and public health responses, including the national Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections (MACBBVS), the Hepatitis B Expert Resource Panel for the WHO Western Pacific Region, and the Global Validation Advisory Committee (GVAC) for the elimination of mother to child transmission of HIV, syphilis and hepatitis B, Global Hepatitis Programme, WHO. He has over 100 peer reviewed publications relating to viral hepatitis, and in 2015 was named the inaugural Director of the WHO Collaborating Centre for Viral Hepatitis at the Doherty Institute.

Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute in Melbourne Australia. Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses; the ultimate aim being to eliminate these infections. Margaret is a member of numerous advisory committees including Co-Chairing the WHO STAC on HIV, viral hepatitis and STIs.

Associate Professor Thomas Tu is a molecular biologist and leads a research group at the Westmead Institute for Medical Research in the Storr Liver Centre (Sydney, Australia), where his team focuses on persistent forms of the Hepatitis B virus (covalently closed circular DNA and integrated HBV DNA) and develops methods to measure and eliminate them. He is particularly passionate about developing an HBV cure and mitigating the associated liver cancer, as he himself lives with chronic Hepatitis B. This provides him with unique perspectives on the disease as a researcher, patient, and advocate. He has won multiple awards for his research and outreach, most recently the 2022 Young Tall Poppy Science award. A/Prof Tu is President of the Australian Centre for Hepatitis Virology, the premier Australian society for hepatitis virus researchers. He is also the founder and Director of HepBCommunity.org (a global support network for people affected with HBV), guiding people through their HBV diagnosis, and linking them with trustworthy scientific and medical information. Recently he has established Hepatitis B Voices Australia, an advocacy group run by the affected community.

In addition to being recognised as a leading clinician in the management of hepatitis B, Ben serves on a range of national and international committees relating to viral hepatitis clinical management and public health responses, including the national Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections (MACBBVS), the Hepatitis B Expert Resource Panel for the WHO Western Pacific Region, and the Global Validation Advisory Committee (GVAC) for the elimination of mother to child transmission of HIV, syphilis and hepatitis B, Global Hepatitis Programme, WHO. He has over 100 peer reviewed publications relating to viral hepatitis, and in 2015 was named the inaugural Director of the WHO Collaborating Centre for Viral Hepatitis at the Doherty Institute.

Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute in Melbourne Australia. Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses; the ultimate aim being to eliminate these infections. Margaret is a member of numerous advisory committees including Co-Chairing the WHO STAC on HIV, viral hepatitis and STIs.

Associate Professor Thomas Tu is a molecular biologist and leads a research group at the Westmead Institute for Medical Research in the Storr Liver Centre (Sydney, Australia), where his team focuses on persistent forms of the Hepatitis B virus (covalently closed circular DNA and integrated HBV DNA) and develops methods to measure and eliminate them. He is particularly passionate about developing an HBV cure and mitigating the associated liver cancer, as he himself lives with chronic Hepatitis B. This provides him with unique perspectives on the disease as a researcher, patient, and advocate. He has won multiple awards for his research and outreach, most recently the 2022 Young Tall Poppy Science award. A/Prof Tu is President of the Australian Centre for Hepatitis Virology, the premier Australian society for hepatitis virus researchers. He is also the founder and Director of HepBCommunity.org (a global support network for people affected with HBV), guiding people through their HBV diagnosis, and linking them with trustworthy scientific and medical information. Recently he has established Hepatitis B Voices Australia, an advocacy group run by the affected community.